Valproate bismuth

DB13910ApprovedSmall molecule

Valproate bismuth is a medication used to treat laryngitis.

Chemical structure of Valproate bismuth
Formula / weight
C24H45BiO6 · 638.598 g/mol (avg)
First approval
Canada, 2013
Also known as
Bismuth dipropylacetate

Resolves to

Compound
UNII87PTX621FICAS60364-28-5
Clinical / RWD
RxNorm324003
Structure
InChIKeyYZDVVHSLIPLZLO-UHFFFAOYSA-KSMILES[Bi+3].CCCC(CCC)C([O-])=O.CCCC(CCC)C([O-])=O.CCCC(CCC)C([O-])=O

What you can answer from here — as of May 03, 2025

332Drug interactionsStructured to mechanism, not free text
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2Marketed productsAcross 1 country and 2 labellers
Sign in

Which other approved drugs treat the same conditions as Valproate bismuth, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In